Mar 12, 2020
The Future of the Alzheimer's Disease Market to 2028 - Featuring 116 Company Profiles and 82 Collaborations
Nov 14, 2019
ProMIS Neurosciences Announces Third Quarter 2019 Results
Oct 14, 2019
Life Molecular Imaging and Positron Pharma announce a strategic partnership for manufacturing and distribution of PI-2620 in Chile
Sep 13, 2019
Eisai And Biogen To Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease
Aug 27, 2019
ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board
Aug 13, 2019
ProMIS Neurosciences Announces Second Quarter 2019 Results
Aug 06, 2019
Alzheimer Disease Drugs, Companies, Markets, 2028
Jul 22, 2019
InvestAcure Honors 10 Leading Scientists With the Cure Coin Award for Work Developing Alzheimer's Diagnostics and Treatments
Jul 18, 2019
BioArctic and Eisai Present New Data Regarding BAN2401 at the Alzheimer's Association International Conference 2019
Jul 17, 2019
Clinical Trial Results At AAIC 2019 Focus On New Ideas And New Targets
Jul 16, 2019
Grifols presents additional encouraging Alzheimer's trial results at AAIC
Jul 15, 2019
Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias
Jun 19, 2019
ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
May 28, 2019
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau
May 10, 2019
Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease
May 10, 2019
BioArctic: Alzheimer's Clinical Trials Consortium and Eisai Announce BAN2401 to be Evaluated in Clinical Study for Prevention of Alzheimer's Disease
Apr 26, 2019
Life Molecular Imaging and Institut de Radiofarmàcia Aplicada de Barcelona (IRAB) Announce a Strategic Partnership for Production of NeuraCeq and PI-2620 in Barcelona
Apr 23, 2019
ProMIS Neurosciences to Participate in the Think Equity Investor Conference
Apr 08, 2019
Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results
Mar 29, 2019
Data Safety Monitoring Board Recommends Continuation Of Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease